drugset / Trial / NCT00214058

Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer

NCT00214058 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer

Timeline

Start
2002-08
Primary completion
—
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Docetaxel Small molecule — —